mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |